Recognition of extraordinary gain (subsidy income)
ベルグ福島株式会社 (consolidated subsidiary)
Research and development business for novel plant vaccines and vaccine-inoculated seedlings
Receipt of a ¥30.054 million subsidy from Fukushima Prefecture under the FY2025 Subsidy for Promotion of Practical Development, etc. for Regional Reconstruction Program
¥30.054 million (extraordinary gain and subsidy income)
Second-quarter accounting period of the fiscal year ending October 2026 (1 February 2026 to 30 April 2026)
Already incorporated into the consolidated earnings forecast for the fiscal year ending October 2026, announced on 15 December 2025
Related procedures
Fukushima Prefecture (subsidy-granting authority)
The amount will be recognized as extraordinary gain under subsidy income in the second-quarter accounting period of the fiscal year ending October 2026.
| Item | Details |
|---|---|
| Event name | Recognition of extraordinary gain (subsidy income) |
| Date of occurrence | 31 March 2026 (date the subsidy was received) |
| Date recognized / date notice received | 31 March 2026 (date the subsidy was received) |
| Subject Entity | ベルグ福島株式会社 (consolidated subsidiary) |
| Target Locations / Products | Research and development business for novel plant vaccines and vaccine-inoculated seedlings |
| Cause | Receipt of a ¥30.054 million subsidy from Fukushima Prefecture under the FY2025 Subsidy for Promotion of Practical Development, etc. for Regional Reconstruction Program |
| Amount of Impact on Business Performance | ¥30.054 million (extraordinary gain and subsidy income) |
| Accounting period in which recognized | Second-quarter accounting period of the fiscal year ending October 2026 (1 February 2026 to 30 April 2026) |
| Impact on Earnings Forecast | Already incorporated into the consolidated earnings forecast for the fiscal year ending October 2026, announced on 15 December 2025 |
| Court or authority | Fukushima Prefecture (subsidy-granting authority) |
| Outlook | The amount will be recognized as extraordinary gain under subsidy income in the second-quarter accounting period of the fiscal year ending October 2026. |
Items this document does not state (14)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.ベルグ福島 received a subsidy from Fukushima Prefecture for its business undertaking research and development of novel plant vaccines and vaccine-inoculated seedlings.